Epidemiological studies show that n-6/n-3 polyunsaturated fatty acid (PUFA) ratios have risen dramatically in Western diets and are associated with numerous chronic inflammation-related diseases. More balanced ratios are linked to less inflammation. This study examines the effects of adding oral supplements containing n-3 eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) to diets of healthy young adults on plasma n-6/n-3 ratios. Thirty volunteers are randomly assigned to one of two groups: experimental group, EPA (1.6 g/day) and DHA (1.2 g/day); and the control group, mineral oil (2.4 ml/day). Plasma fatty acids, nutrients from foods, and anthropometric measures are evaluated at baseline and at the Week 4 endpoint. The mean (±SD) n-6/n-3 ratio for the experimental group is significantly lower (6.3 ± 1.6) than the placebo group (16.8 ± 3.5) by study completion. The results suggest that more balanced n-6/n-3 ratios may be achieved efficiently in healthy, young adults with supplements containing EPA and DHA.
Alexander, J.W. ( 1998). Immunonutrition: The role of omega-3 fatty acids. Nutrition, 14, 627-633.
2.
Arab, L. ( 2003). Biomarkers of fat and fatty acid intake. The Journal of Nutrition, 133(Suppl. 3), 925S-932S.
3.
Arterburn, L.M., Hall, E.B., & Oken, H. ( 2006). Distribution, interconversion, and dose response of n-3 fatty acids in humans. The American Journal of Clinical Nutrition , 83(Suppl. 6), 1467S-1476S.
4.
Balk, E., Chung, M., Lichtenstein, A., Chew, P., Kupelnick, B., Lawrence, A., et al. (2004). Effects of omega-3 fatty acids on cardiovascular risk factors and intermediate markers of cardiovascular disease. Evidence Report/Technology Assessment (Summary), 93, 1-6.
5.
Blok, W.L., Katan, M.B., & van der Meer, J.W. (1996). Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. The Journal of Nutrition, 126, 1515-1533.
6.
Calder, P.C. ( 2006). n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. The American Journal of Clinical Nutrition, 83(Suppl. 6), 1505S-1519S.
7.
Caughey, G.E., Mantzioris, E., Gibson, R.A., Cleland, L.G., & James, M.J. ( 1996). The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. The American Journal of Clinical Nutrition, 63, 116-122.
8.
Deckelbaum, R.J., Worgall, T.S., & Seo, T. ( 2006). n-3 fatty acids and gene expression. The American Journal of Clinical Nutrition, 83(Suppl. 6), 1520S-1525S.
9.
Eaton, S.B., & Konner, M. ( 1985). Paleolithic nutrition: A consideration of its nature and current implications. The New England Journal of Medicine , 312, 283-289.
10.
Emken, E.A., Adlof, R.O., & Gulley, R.M. ( 1994). Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochimica Et Biophysica Acta, 1213, 277-288.
11.
Endres, S., Ghorbani, R., Kelley, V.E., Georgilis, K., Lonnemann, G., van der Meer, J.W., et al. (1989). The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. The New England Journal of Medicine, 320, 265-271.
12.
Ervin, R.B., Wright, J.D., Wang, C., & Kennedy-Stephenson, J. (2004). Dietary intake of fats and fatty acids for the United States population: 1999-2000. Advance Data, 348, 1-6.
13.
Fernandes, J. ( 2002). Voeding en gezondheid-aanbevelingen van de Gezondheidsraad voor energie, eiwitten, vetten en koolhydraten [Nutrition and health-Recommendations of the Health Council of the Netherlands regarding energy, proteins, fats and carbohydrates]. Nederlands Tijdschrift Voor Geneeskunde , 146, 2226-2229.
14.
Ferrucci, L., Cherubini, A., Bandinelli, S., Bartali, B., Corsi, A., Lauretani, F., et al. (2006). Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. The Journal of Clinical Endocrinology and Metabolism, 91, 439-446.
15.
Gebauer, S.K., Psota, T.L., Harris, W.S., & Kris-Etherton, P.M. (2006). n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. The American Journal of Clinical Nutrition, 83, 1526S-1535S.
16.
Glaser, R., Kiecolt-Glaser, J.K., Marucha, P.T., MacCallum, R.C., Laskowski, B.F., & Malarkey, W.B. (1999). Stress-related changes in proinflammatory cytokine production in wounds. Archives of General Psychiatry, 56, 450-456.
17.
Grimm, H., Mayer, K., Mayser, P., & Eigenbrodt, E. (2002). Regulatory potential of n-3 fatty acids in immunological and inflammatory processes. The British Journal of Nutrition, 87(Suppl. 1), S59-S67.
18.
Harris, W.S. ( 2004). Fish oil supplementation: Evidence for health benefits . Cleveland Clinic Journal of Medicine, 71, 208-221.
19.
Harris, W.S., Pottala, J.V., Sands, S.A., & Jones, P.G. ( 2007). Comparison of the effects of fish and fish-oil capsules on the n 3 fatty acid content of blood cells and plasma phospholipids. The American Journal of Clinical Nutrition, 86, 1621-1625.
20.
Hussein, N., Ah-Sing, E., Wilkinson, P., Leach, C., Griffin, B.A., & Millward, D.J. (2005). Long-chain conversion of [13C]linoleic acid and alpha-linolenic acid in response to marked changes in their dietary intake in men. Journal of Lipid Research , 46, 269-280.
21.
Institute of Medicine. (2002). Dietary reference intakes for energy, carbohydrates, fiber, fat, fatty acids, cholesterol, protein, and amino acidsWashington, DC: National Academies Press.
22.
International Society for the Study of Fatty Acids and Lipids. (2004). Recommendation for intake of polyunsaturated fatty acids in healthy adults. Brighton, UK: Author.
23.
Kafatos, A., & Codrington, C.A. (1999). Nutrition and diet for healthy lifestyles in Europe: The "Eurodiet" Project. Public Health Nutrition, 2(3A), 327-328.
24.
Kim, D.N., Schmee, J., & Thomas, W.A. ( 1990). Dietary fish oil added to a hyperlipidemic diet for swine results in reduction in the excessive number of monocytes attached to arterial endothelium. Atherosclerosis, 81, 209-216.
25.
Lichtenstein, A.H., Appel, L.J., Brands, M., Carnethon, M., Daniels, S., Franch, H.A., et al. (2006). Summary of American heart association diet and lifestyle recommendations revision 2006. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 2186-2191.
26.
McDaniel, J.C., Belury, M., Ahijevych, K., & Blakely, W. ( 2008). Omega-3 fatty acids effect on wound healing. Wound Repair and Regeneration, 16, 337-345.
27.
Meydani, S.N., Endres, S., Woods, M.M., Goldin, B.R., Soo, C., Morrill-Labrode, A., et al. (1991). Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: Comparison between young and older women. The Journal of Nutrition, 121, 547-555.
28.
Robinson, J.G., & Stone, N.J. ( 2006). Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids. The American Journal of Cardiology, 98(4A), 39i-49i.
29.
Rupp, H., Wagner, D., Rupp, T., Schulte, L., & Maisch, B. ( 2004). Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio." Herz, 29, 673-685.
30.
Sijben, J., & Calder, P. ( 2007). Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease. The Proceedings of the Nutrition Society, 66, 237.
31.
Simopoulos, A.P. ( 1989). Summary of the NATO advanced research workshop on dietary omega 3 and omega 6 fatty acids: Biological effects and nutritional essentiality . The Journal of Nutrition, 119, 521-528.
32.
Simopoulos, A.P. ( 1995a). Evolutionary aspects of diet: Fatty acids, insulin resistance and obesity. In T. B. VanItalie & A. P. Simopoulos (Eds.), Obesity: New directions in assessment and management (pp. 241-261). Philadelphia: Charles Press.
33.
Simopoulos, A.P. ( 1995b). Trans fatty acids. In G. A. Spiller (Ed.), Handbook of lipids in human nutrition (pp. 91-99). Boca Raton, FL: CRC Press.
34.
Simopoulos, A.P. ( 1999). Evolutionary aspects of omega-3 fatty acids in the food supply. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 60, 421-429.
35.
Simopoulos, A.P. ( 2002). The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedicine & Pharmacotherapy, 56, 365-379.
36.
Simopoulos, A.P. ( 2008a). The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Experimental Biology and Medicine, 233, 674-688.
37.
Simopoulos, A.P. ( 2008b). The omega-6/omega-3 fatty acid ratio, genetic variation, and cardiovascular disease. Asia Pacific Journal of Clinical Nutrition, 17(Suppl. 1), 131-134.
38.
Stevens, J.P. ( 2002). Applied multivariate statistics for the social sciences (4th ed.). Mahwah, NJ: Lawrence Erlbaum.
39.
UK Scientific Advisory Committee on Nutrition. ( 2004). Advice on fish consumption: Benefits & risks. London: The Stationary Office.
40.
Vermunt, S.H., Mensink, R.P., Simonis, M.M., & Hornstra, G. ( 2000). Effects of dietary alpha-linolenic acid on the conversion and oxidation of 13C-alpha-linolenic acid. Lipids, 35, 137-142.
41.
World Health Organization. (2003). Diet, nutrition, and the prevention of chronic diseases (Technical Report No. 916)Geneva: Author.
